Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordi Remon

Showing results (51-60 of 184) with videos related to

Pageof 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2021
Paving the Way for Long-Term Survival in Non-Small-Cell Lung CancerJordi Remon, Lizza E L Hendriks, Benjamin Besse
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2019
Immune-Related Adverse Events and Outcomes in Patients with Advanced Non-Small Cell Lung Cancer: A Predictive Marker of Efficacy?Jordi Remon, Noemí Reguart, Edouard Auclin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Crizotinib Improves Osteoarthritis Symptoms in a ROS1-Fusion Advanced Non-Small Cell Lung Cancer PatientJordi Remon, Anas Gazzah, Benjamin Besse, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Future Genetic/Genomic Biomarker Testing in Non-Small Cell Lung CancerDavid Planchard, Jordi Remon, Frédérique Nowak, et al.
Journal of Thoracic Disease|April 19, 2019
Could WNT inhibitors really knock on the treatment door of small cell lung cancer?Laura Esteller, Susana Hernández, Fernando Lopez-Rios, et al.
JTO Clinical and Research Reports|September 30, 2021
Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal MetastasesJordi Remon, María Castro-Henriques, Laura Esteller, et al.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2022
Who benefits from consolidation durvalumab in stage III non-small cell lung cancer?Dirk De Ruysscher, Jordi Remon, Lizza E L Hendriks
The European Respiratory Journal|December 2, 2015
Circulating free DNA, new dynamic marker in nonsmall cell lung cancer patients?Jordi Remon, Julie Gorham, Benjamin Besse, et al.
Translational Lung Cancer Research|July 23, 2021
Is there any opportunity for immune checkpoint inhibitor therapy in non-small cell lung cancer patients with brain metastases?Lizza E L Hendriks, Jordi Remon, Jessica Menis, et al.
Drugs|January 9, 2020
In Search of the Long-Desired 'Copernican Therapeutic Revolution' in Small-Cell Lung CancerNoemí Reguart, Elba Marin, Jordi Remon, et al.
Pageof 19

Showing results (51-60 of 184) with videos related to

Sort By:
Pageof 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2021
Paving the Way for Long-Term Survival in Non-Small-Cell Lung CancerJordi Remon, Lizza E L Hendriks, Benjamin Besse
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2019
Immune-Related Adverse Events and Outcomes in Patients with Advanced Non-Small Cell Lung Cancer: A Predictive Marker of Efficacy?Jordi Remon, Noemí Reguart, Edouard Auclin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 23, 2015
Crizotinib Improves Osteoarthritis Symptoms in a ROS1-Fusion Advanced Non-Small Cell Lung Cancer PatientJordi Remon, Anas Gazzah, Benjamin Besse, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Future Genetic/Genomic Biomarker Testing in Non-Small Cell Lung CancerDavid Planchard, Jordi Remon, Frédérique Nowak, et al.
Journal of Thoracic Disease|April 19, 2019
Could WNT inhibitors really knock on the treatment door of small cell lung cancer?Laura Esteller, Susana Hernández, Fernando Lopez-Rios, et al.
JTO Clinical and Research Reports|September 30, 2021
Combination of Atezolizumab, Bevacizumab, and Chemotherapy (IMpower 150) in a Patient With NSCLC Having Leptomeningeal MetastasesJordi Remon, María Castro-Henriques, Laura Esteller, et al.
European Journal of Cancer (Oxford, England : 1990)|March 21, 2022
Who benefits from consolidation durvalumab in stage III non-small cell lung cancer?Dirk De Ruysscher, Jordi Remon, Lizza E L Hendriks
The European Respiratory Journal|December 2, 2015
Circulating free DNA, new dynamic marker in nonsmall cell lung cancer patients?Jordi Remon, Julie Gorham, Benjamin Besse, et al.
Translational Lung Cancer Research|July 23, 2021
Is there any opportunity for immune checkpoint inhibitor therapy in non-small cell lung cancer patients with brain metastases?Lizza E L Hendriks, Jordi Remon, Jessica Menis, et al.
Drugs|January 9, 2020
In Search of the Long-Desired 'Copernican Therapeutic Revolution' in Small-Cell Lung CancerNoemí Reguart, Elba Marin, Jordi Remon, et al.
Pageof 19